ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9821
-1.00%
Brent Oil
83.54
-2.74%
Bitcoin
57,987.97
-4.31%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) Noticias

CERE Cerevel Therapeutics Holdings Inc

42.63
-0.08 (-0.19%)
Fuera de horario
Última actualización: 15:02:50
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cerevel Therapeutics Holdings Inc CERE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.08 -0.19% 42.63 15:02:50
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
42.73 42.60 42.86 42.63 42.71
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202405:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
27/2/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202415:46EDGAR2Form 8-K - Current report
09/2/202408:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/2/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202407:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
23/1/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202406:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
18/1/202406:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05/1/202416:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
02/1/202417:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
28/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202316:03EDGAR2Form 144 - Report of proposed sale of securities
21/12/202319:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202305:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
07/12/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202315:32EDGAR2Form 144 - Report of proposed sale of securities
07/12/202315:31EDGAR2Form 144 - Report of proposed sale of securities
07/12/202307:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202307:00EDGAR2Form 8-K - Current report
07/12/202305:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
06/12/202322:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
06/12/202315:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
05/12/202317:42EDGAR2Form 144 - Report of proposed sale of securities
29/11/202305:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
08/11/202305:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
01/11/202305:39EDGAR2Form 8-K - Current report
01/11/202305:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
18/10/202315:32EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202305:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
12/10/202315:19EDGAR2Form 8-K - Current report
12/10/202315:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202321:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
11/10/202315:14EDGAR2Form 8-K - Current report
11/10/202315:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202315:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

Su Consulta Reciente

NASDAQ
CERE
Cerevel Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados